These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3807834)

  • 21. Renal osteodystrophy in CAPD.
    Hutchison AJ; Freemont AJ; Lumb GA; Gokal R
    Adv Perit Dial; 1991; 7():237-9. PubMed ID: 1680434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.
    Weinstein RS
    Calcif Tissue Int; 1982 Jan; 34(1):16-20. PubMed ID: 6802455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone histomorphometry of renal osteodystrophy in diabetic patients.
    Andress DL; Hercz G; Kopp JB; Endres DB; Norris KC; Coburn JW; Sherrard DJ
    J Bone Miner Res; 1987 Dec; 2(6):525-31. PubMed ID: 3455634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
    Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
    J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.
    Carbonara CEM; Reis LMD; Quadros KRDS; Roza NAV; Sano R; Carvalho AB; Jorgetti V; Oliveira RB
    J Bras Nefrol; 2020 Jan; 42(2):138-146. PubMed ID: 32756862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.
    Kopp JB; Andress DL; Maloney NA; Sherrard DJ
    Am J Kidney Dis; 1988 Sep; 12(3):214-9. PubMed ID: 3414677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.
    Lehmann G; Ott U; Stein G; Steiner T; Wolf G
    Transplant Proc; 2007 Dec; 39(10):3153-8. PubMed ID: 18089342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant of adynamic bone disease in hemodialysis patients: fact or fiction?
    Rocha LA; Higa A; Barreto FC; dos Reis LM; Jorgetti V; Draibe SA; Carvalho AB
    Am J Kidney Dis; 2006 Sep; 48(3):430-6. PubMed ID: 16931216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
    Rojas E; Carlini RG; Clesca P; Arminio A; Suniaga O; De Elguezabal K; Weisinger JR; Hruska KA; Bellorin-Font E
    Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of aluminum-associated bone disease in long-term hemodialysis patients.
    Iwamoto N; Ono T; Yamazaki S; Fukuda T; Kondo M; Yamamoto N; Hiratake Y; Masugi Y; Kubo Y; Hino M
    Nephron; 1986; 42(3):204-9. PubMed ID: 3945360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of renal osteodystrophy in hemodialysis patients.
    DeVita MV; Rasenas LL; Bansal M; Gleim GW; Zabetakis PM; Gardenswartz MH; Michelis MF
    Medicine (Baltimore); 1992 Sep; 71(5):284-90. PubMed ID: 1522804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of adynamic bone disease in dialyzed patients.
    Malluche HH; Monier-Faugere MC
    Kidney Int Suppl; 1992 Oct; 38():S62-7. PubMed ID: 1405383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.
    Libbey NP; Chazan JA; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1993 Apr; 39(4):214-23. PubMed ID: 8491052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.